
Coherence Neuro
Investigational neurotechnology for monitoring and treating cancer from inside the body
- Industry
- MedTech
- Founded
- 2022
- Based in
- United Kingdom
Verified revenue: not connected yet
Is Coherence Neuro yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.
About
Coherence Neuro is developing neurotechnology, including the CIPHER System and the SOMA brain-computer interface, to monitor cancer and deliver therapeutic stimulation. Its devices are investigational and not approved by the FDA or TGA; a first-in-human study started in Melbourne in 2026. It is based in San Francisco and backed by Armenia-based SmartGate VC.
Team
- Ben Woodington, Co-founder and CEO (Founder)
- Elise Jenkins, Co-founder and CTO (Founder)
Audience
Followers on social networks
Profile data from Stanbase.